Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lexaria Bioscience (LEXX) Interest & Investment Income (2023 - 2025)

Lexaria Bioscience's Interest & Investment Income history spans 3 years, with the latest figure at $12.0 for Q4 2025.

  • For Q4 2025, Interest & Investment Income rose 9.09% year-over-year to $12.0; the TTM value through Nov 2025 reached $3018.0, down 56.9%, while the annual FY2025 figure was $3017.0, 78.92% down from the prior year.
  • Interest & Investment Income for Q4 2025 was $12.0 at Lexaria Bioscience, down from $2816.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $7319.0 in Q4 2023 and bottomed at -$1.0 in Q1 2024.
  • The 3-year median for Interest & Investment Income is $190.0 (2025), against an average of $2477.1.
  • The largest annual shift saw Interest & Investment Income crashed 99.85% in 2024 before it increased 9.09% in 2025.
  • A 3-year view of Interest & Investment Income shows it stood at $7319.0 in 2023, then plummeted by 99.85% to $11.0 in 2024, then grew by 9.09% to $12.0 in 2025.
  • Per Business Quant, the three most recent readings for LEXX's Interest & Investment Income are $12.0 (Q4 2025), $2816.0 (Q3 2025), and $190.0 (Q2 2025).